Work

HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Year: 2012

Type: article

Source: Ophthalmology

DOI: 10.1016/j.ophtha.2011.12.016

Authors: Michael A. Singer, Carl C. Awh, SriniVas Sadda, William R. Freeman, Andrew N. Antoszyk, Pamela Wong, Lisa Tuomi

Institutions: Medical Center Ophthalmology Associates, Tennessee Retina, Doheny Eye Institute, University of California San Diego, Charlotte Eye Ear Nose & Throat Associates, Genentech

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2011393181

FWCI: 30.13

Cites: 11

Cited by: 357

Related to: 10